Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
주식 순위 #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
주가
$0.94
마지막 동기화: 2025-02-28
시가총액
$2.73M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Fresh Tracks Therapeutics, Inc. (FRTX)

카테고리

Fresh Tracks Therapeutics, Inc. (FRTX)의 영업이익률
August 2026 기준 영업이익률 TTM: -79.44%
Fresh Tracks Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 -79.44%입니다. 2022년 말 기준 영업이익률은 -310.15%였습니다.
Fresh Tracks Therapeutics, Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) -79.44% 0.00%
2023 -79.44% -74.39%
2022 -310.15% -96.89%
2021 -9,961.39% 765.26%
2020 -1,151.26% 272.50%
2019 -309.06% -74.48%
2018 -1,211.22% 1,150.36%
2017 -96.87% 53.40%
2016 -63.15% 40.68%
2015 -44.89% -58.91%
2014 -109.26% -73.10%
2013 -406.22% 203.69%
2012 -133.76% 413.28%
2011 -26.06% -92.73%
2010 -358.34% 59.02%
2009 -225.34% -51.99%
2008 -469.37% -35.74%
2007 -730.44% 307.57%
2006 -179.22% -16.13%
2005 -213.70% 23.63%
2004 -172.86% -46.50%
2003 -323.12% -28.41%
2002 -451.36% 197.75%
2001 -151.59% -28.52%
2000 -212.06% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
38.59% -100.49%
US
28.81% -100.36%
NL
0.00% -
CH
0.00% -
KR
31.23% -100.39%
BE
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.